XML 60 R41.htm IDEA: XBRL DOCUMENT v3.20.4
Revenues from Contracts with Customers
6 Months Ended
Dec. 31, 2020
Revenue from Contract with Customer [Abstract]  
Revenues from Contracts with Customers REVENUES FROM CONTRACTS WITH CUSTOMERS
Disaggregation of Revenue from Contracts with Customers—The disaggregation of revenue by segment and product is depicted for the periods presented below, and is consistent with how the Company evaluates its financial performance:
Three Months Ended December 31,Six Months Ended December 31,
(in thousands)2020201920202019
Senior:
Commission revenue:
Medicare advantage$263,975 $113,955 $312,705 $134,142 
Medicare supplement12,743 9,303 20,735 13,453 
Prescription drug plan1,102 1,659 1,717 2,036 
Dental, vision, and hearing5,647 2,223 8,370 3,224 
Other commission revenue743 211 1,203 159 
Total commission revenue284,210 127,351 344,730 153,014 
Production bonus and other revenue31,300 11,524 43,979 13,444 
Total Senior revenue
315,510 138,875 388,709 166,458 
Life:
Commission revenue:
Core19,791 19,119 39,167 37,703 
Final expense10,297 3,391 27,934 6,885 
Ancillary465 686 1,049 1,254 
Total commission revenue30,553 23,196 68,150 45,842 
Production bonus and other revenue5,822 5,784 11,048 10,745 
Total Life revenue
36,375 28,980 79,198 56,587 
Auto & Home:
Total commission revenue6,491 8,227 15,104 17,816 
Production bonus and other revenue750 339 1,675 803 
Total Auto & Home revenue
7,241 8,566 16,779 18,619 
Eliminations:
Total commission revenue(280)(124)(465)(200)
Production bonus and other revenue(572)— (1,778)— 
Total Elimination revenue
(852)(124)(2,243)(200)
Total commission revenue320,974 158,650 427,519 216,472 
Total production bonus and other revenue37,300 17,647 54,924 24,992 
Total revenue
$358,274 $176,297 $482,443 $241,464 
Contract Balances—After a policy is sold, the Company has no material additional or recurring obligations to the policyholder or the insurance carrier. As such, there are no contract liabilities recorded in the condensed consolidated balance sheets. As there is no activity in the contract asset balances other than the movement over time between long-term and short-term commissions receivable and accounts receivable as the policy is renewed, a separate roll forward other than what is shown on the condensed consolidated balance sheets is not relevant. Cumulative revenue catch-up adjustments related to changes in the estimates of transaction prices were not material for the three and six months ended December 31, 2020 and 2019.
Production Bonuses and Other—During the six months ended December 31, 2020, the Company received advance payments of fiscal year 2021 marketing development funds, which will be amortized over the course of the year based on policies sold. As of December 31, 2020, there was an unamortized balance remaining of $17.3 million recorded in other current liabilities in the condensed consolidated balance sheet.
REVENUES FROM CONTRACTS WITH CUSTOMERS
Disaggregation of Revenue from Contracts with Customers—The disaggregation of revenue by segment and product is depicted for the periods presented below, and is consistent with how the Company evaluates its financial performance:
Year Ended June 30,
(in thousands)202020192018
Senior:
Commission revenue:
Medicare advantage$285,957 $138,526 $62,537 
Medicare supplement34,301 25,118 26,189 
Prescription drug plan2,867 3,209 2,985 
Dental, vision, and health7,758 4,470 2,932 
Other commission revenue362 2,526 2,345 
Total commission revenue331,245 173,849 96,988 
Production bonus and other revenue30,428 18,408 5,420 
Total Senior revenue
$361,673 $192,257 $102,408 
Life:
Commission revenue:
Term$75,236 $76,135 $71,951 
Other commission revenue32,628 13,111 5,850 
Total commission revenue107,864 89,246 77,801 
Production bonus and other revenue22,103 21,247 20,417 
Total Life revenue
$129,967 $110,493 $98,218 
Auto & Home:
Total commission revenue$38,031 $33,240 $32,108 
Production bonus and other revenue3,158 1,814 1,240 
Total Auto & Home revenue
$41,189 $35,054 $33,348 
Eliminations:
Total commission revenue$(534)$(335)$(286)
Production bonus and other revenue(780)— — 
Total Elimination revenue
$(1,314)$(335)$(286)
Total commission revenue476,606 296,000 206,611 
Total production bonus and other revenue54,909 41,469 27,077 
Total revenue
$531,515 $337,469 $233,688 
Contract Balances—After a policy is sold, the Company has no material additional or recurring obligations to the policyholder or the insurance carrier. As such, there are no contract liabilities recorded in the consolidated balance sheets. As there is no activity in the contract asset balances other than the movement over time between long-term and short-term commissions receivable and accounts receivable as the policy is renewed, a separate roll forward other than what is shown on the consolidated balance sheets is not relevant. Cumulative revenue catch-up adjustments related to changes in the estimates of transaction prices were not material for the years ended June 30, 2020, 2019, and 2018.